Bio-Techne (TECH) Accumulated Expenses (2010 - 2026)

Bio-Techne's Accumulated Expenses history runs 17 years deep, the most recent figure standing at $17.7 million for Q1 2026.

• In Q1 2026, Accumulated Expenses fell 71.43% year-over-year to $17.7 million; the TTM figure through Mar 2026 stood at $17.7 million (down 71.43% YoY), while the FY2025 annual figure was $25.7 million, down 48.49% from the prior year.
• Accumulated Expenses was $17.7 million for Q1 2026 at Bio-Techne, down from $45.0 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $62.0 million in Q2 2022 to a low of $13.8 million in Q3 2022.
• Historically, Accumulated Expenses has averaged $36.1 million across 5 years, with a median of $36.7 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Accumulated Expenses surged 305.4% in 2022, then plunged 71.43% in 2026.
• A 5-year view of Accumulated Expenses shows it stood at $16.3 million in 2022, then jumped by 102.68% to $33.0 million in 2023, then jumped by 62.43% to $53.6 million in 2024, then dropped by 15.99% to $45.0 million in 2025, then sank by 60.73% to $17.7 million in 2026.
• The last three Accumulated Expenses figures came in at $17.7 million (Q1 2026), $45.0 million (Q4 2025), and $19.2 million (Q3 2025), per Business Quant data.